Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF NOVEL PPAR ACTIVITY MODULATOR FOR PREVENTION, AMELIORATION OR TREATMENT OF DEGENERATIVE BRAIN DISEASES
Document Type and Number:
WIPO Patent Application WO/2024/029962
Kind Code:
A1
Abstract:
The present invention relates to use of a novel PPAR activity modulator for the prevention, amelioration or treatment of degenerative brain diseases and, more specifically, provides a composition for the prevention, amelioration or treatment of degenerative brain diseases by using a PPAR active agent that binds to and activate all subtypes of PPAR, and a composition for enhancing learning ability, improving memory, or ameliorating cognitive decline. Also, the present invention provides a method for the prevention, amelioration or treatment of degenerative brain diseases by using the novel PPAR active agent, and a method for enhancing learning ability, improving memory, or ameliorating cognitive decline.

Inventors:
KIM KYONGTAI (KR)
KANG JEONGHWA (KR)
OH EUNJI (KR)
JUNG HOE YUNE (KR)
LEE HEON JONG (KR)
Application Number:
PCT/KR2023/011420
Publication Date:
February 08, 2024
Filing Date:
August 03, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
POSTECH RES & BUSINESS DEV FOUND (KR)
NOVMETAPHARMA CO LTD (KR)
International Classes:
A61K31/405; A23L33/10; A61P25/28
Foreign References:
KR20190085443A2019-07-18
KR20030007104A2003-01-23
KR20190135177A2019-12-06
KR20210070083A2021-06-14
Other References:
DATABASE Registry CAS; 27 November 2007 (2007-11-27), ANONYMOUS : "L-Tryptophan, N-[(1,1-dimethyle thoxy)carbonyl]-, 4-(4-methoxyphenyl)-8-met hyl-2-oxo-2H-1-benzopyran7-yl ester", XP093136808, retrieved from STN Database accession no. 956044-42-1
Attorney, Agent or Firm:
ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF: